RARE Health Equity Summit

November 9-11, 2022 | USA

RARE_Health_Equity
The RARE Health Equity Summit was developed in order to gain a better understanding of persistent gaps in diagnostic challenges for underserved/underrepresented patient communities and align next steps on how to address health inequities of the rare disease community.

Spotlight

Genome-editing system CRISPR is now being accused of causing cancer. The system has previously been celebrated for its advancements in curing disease. However, Geek reports that two studies published this week warn that cells altered by CRISPR-Cas9 can trigger cancer. The CEO of CRISPR Therapeutics called the findings “plausible." Stocks have since crashed in companies trying to make the technology mainstream.


OTHER PAST CONFERENCES

Hospitalist and Internal Medicine: Inpatient and Outpatient Care

June 13-16, 2022 | USA

Demonstrate the importance of the history and physical exam including patterns of joints involvement and extra-articular findings in evaluating patients with rheumatic diseases. Distinguish inflammatory (i.e. rheumatoid arthritis) and structural arthritis (i.e. osteoarthritis). Differentiate patterns of articular involvement associated with different arthritides. Utilize laboratory and radiological studies in the evaluation of patients with rheumatic diseases.

Evolution and Core Processes in Gene Expression

July 21-24, 2022 | USA

The focus of this meeting is to discuss the most recent insights into the cis-regulatory code, how cis-regulatory information is read out by transcription factors, signaling pathways and other proteins, how cellular diversity is created during development and how we can study this problem using cutting-edge genomics technology and computational methods.

BioProcess International Conference

September 27-30, 2022 | USA

Each year, BPI’s scientific agenda includes 200+ of the industry’s top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.

1st Conference of the Researcher Mental Health Observatory (ReMO 2022)

August 25-26, 2022 | USA

The ReMO COST Action focuses on wellbeing and mental health within academia, a theme of strategic importance for the European Research Area and beyond. We would like to invite our fellow researchers and practitioners to critically think about Bridging Research and Practice in Fostering Healthy Academic Workplaces. How can stakeholders in the research environment contribute to tackling this challenge in a rapidly changing world? We therefore hope for an inspiring conference with presentations, workshops and keynotes that will not only showcase the newest findings about the cognitive, motivational, and emotional aspects of Researcher Mental Health and Well-being, but will also be a place to discuss the global challenges that shape the present and will define the future of our research workplaces.

Spotlight

Genome-editing system CRISPR is now being accused of causing cancer. The system has previously been celebrated for its advancements in curing disease. However, Geek reports that two studies published this week warn that cells altered by CRISPR-Cas9 can trigger cancer. The CEO of CRISPR Therapeutics called the findings “plausible." Stocks have since crashed in companies trying to make the technology mainstream.

resources